BRIEF published on 03/25/2024 at 15:27, 2 years 5 months ago Vanguard Group augmente sa participation dans Ageas SA/NV Actionnariat Opérations Boursières Groupe D'avant-garde Ageas SA/NV Investissements Financiers
BRIEF published on 03/25/2024 at 15:27, 2 years 5 months ago Vanguard Group Increases Stake in Ageas SA/NV Vanguard Group Shareholding Stock Transactions Ageas SA/NV Financial Investments
PRESS RELEASE published on 03/25/2024 at 15:22, 2 years 5 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.46% stake in Ageas SA/NV as of 22 March 2024. Additional disclosures related to Direct Line Insurance Group plc and recent securities transactions are provided in Form 8.3 Securities Transactions The Vanguard Group, Inc. Disclosure Ageas SA/NV
BRIEF published on 03/22/2024 at 15:26, 2 years 5 months ago Vanguard annonce une participation dans Ageas SA/NV Marchés Financiers Groupe D'avant-garde Ageas SA/NV Divulgation Des Titres Investissement Dans Le Secteur Des Assurances
BRIEF published on 03/22/2024 at 15:26, 2 years 5 months ago Vanguard Reports Stake in Ageas SA/NV Securities Disclosure Vanguard Group Financial Markets Ageas SA/NV Insurance Sector Investment
PRESS RELEASE published on 03/22/2024 at 15:21, 2 years 5 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses 3.46% ownership in Ageas SA/NV as of 21 March 2024. Also making disclosures related to Direct Line Insurance Group plc Disclosure Vanguard Group Inc. Ownership Ageas SA/NV Direct Line Insurance Group Plc
BRIEF published on 03/21/2024 at 15:11, 2 years 5 months ago Vanguard Group dévoile sa participation dans Ageas SA/NV Marchés Financiers Groupe D'avant-garde Ageas SA/NV Divulgation Des Titres Détention D'investissement
BRIEF published on 03/21/2024 at 15:11, 2 years 5 months ago Vanguard Group Discloses Stake in Ageas SA/NV Securities Disclosure Vanguard Group Financial Markets Ageas SA/NV Investment Holding
PRESS RELEASE published on 03/21/2024 at 15:06, 2 years 5 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.46% stake in Ageas SA/NV as of 20 March 2024. Details include securities holdings and recent transactions Financial Transactions The Vanguard Group, Inc. Form 8.3 Disclosure Ageas SA/NV Securities Holdings
BRIEF published on 03/20/2024 at 14:27, 2 years 5 months ago Vanguard Increases Stake in Ageas SA/NV Vanguard Group Financial Markets Share Ownership Ageas SA/NV Insurance Sector
Published on 09/10/2026 at 22:25, 10 hours 35 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 40 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 08:15, 45 minutes ago EQS-Adhoc: Airbus SE: Airbus commences limited share buyback to support future employee share ownership plan activities and equity-based compensation
Published on 09/11/2026 at 08:02, 58 minutes ago PUMA CCO Matthias Baeumer to step down from Management Board
Published on 09/11/2026 at 07:30, 1 hour 30 minutes ago NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 00:05, 8 hours 55 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 07:00, 2 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 30 minutes ago Availability of the 2026 Interim Financial Report
